PD23-06: Radiographic Progression-Free Survival as a Meaningful Endpoint in Metastatic Castration-Resistant Prostate Cancer (mCRPC): The TALAPRO-2 Randomized Clinical Trial
Sunday, May 17, 2026 4:10 PM to 4:18 PM · 8 min. (America/New_York)
206
Abstract
